Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [5899]

Cryotherapy could be a game changer for patients with early-stage kidney cancer

Cryotherapy could be a game changer for patients with early-stage kidney cancer

Overcoming ovarian cancer’s resistance to immunotherapy

Overcoming ovarian cancer’s resistance to immunotherapy

Innovative combination therapy shows promising efficacy in aggressive leukaemia

Innovative combination therapy shows promising efficacy in aggressive leukaemia

Researchers played music to cells – aggressiveness of laryngeal cancer decreased

Researchers played music to cells – aggressiveness of laryngeal cancer decreased

ASCO GU 2026: Belzutifan plus pembrolizumab post-surgery helps ccRCC patients at high risk for relapse stay cancer-free longer

ASCO GU 2026: Belzutifan plus pembrolizumab post-surgery helps ccRCC patients at high risk for relapse stay cancer...

ASCO GU 2026: Combo targeting blood vessel growth controls ccRCC better than single agent

ASCO GU 2026: Combo targeting blood vessel growth controls ccRCC better than single agent

FDA grants accelerated approval to zongertinib for unresectable or metastatic non-squamous non-small cell lung cancer

FDA grants accelerated approval to zongertinib for unresectable or metastatic non-squamous non-small cell lung...

ASCO GU 2026: Enfortumab vedotin pembrolizumab combo may reduce risk of recurrence for some MIBC cases

ASCO GU 2026: Enfortumab vedotin pembrolizumab combo may reduce risk of recurrence for some MIBC cases

FDA approves acalabrutinib with venetoclax for chronic lymphocytic leukeamia or small lymphocytic lymphoma

FDA approves acalabrutinib with venetoclax for chronic lymphocytic leukeamia or small lymphocytic lymphoma

Senescence behind the aggressive nature of postpartum breast cancer

Senescence behind the aggressive nature of postpartum breast cancer

More from ecancer